Recorded device evidence

AUTOPULSE RESUSCITATION SYSTEM MODEL 1000 (K112998): indications, design and recorded evidence

The acquired K112998 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 2 selected decisions under primary code DRM. 2 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K112998 ↗ · this pageAUTOPULSE RESUSCITATION SYSTEM MODEL 10002011-10-07 → 2012-03-15160Traditional
K221700 ↗AutoPulse NXT Resuscitation System2022-06-13 → 2023-03-09269Traditional
K211289 ↗RMU-2000 Automated Chest Compression System2021-04-28 → 2021-11-09195Traditional
K173553 ↗LUCAS 3 Chest Compression System2017-11-16 → 2018-02-0884Traditional
K161768 ↗LUCAS 3 Chest Compression System2016-06-27 → 2016-11-09135Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K112998 · PDF page 6 ↗ Source 2

The    AutoPulse           Resuscitation      System           Model             100     is intended         to         be      used           as     an           adjunct     tocases      of clinical       death        as      defined          by       lack       of
manual         CPR,         on         adult  patients       only,      in
spontaneous       breathing         and          pulse.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K112998 · PDF page 2 ↗ Source 3

The        AutoPulse      Resuscitation            System         Model         100         is an         automated,            portable,        battery
powered        device       that     compresses     the      chest     of     an     adult       human            as      an     adjunct     to           manual
CPR.                A brief   description       of the      device         is provided          below.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K112998 · PDF page 2 ↗ Source 3

The        changes         included         in this     51 0(k)        application         include    the      introduction          of     new      Li-Ion
battery     and        a multi-chemistry        charger,        capable     of     charging       the      current        NiMH        battery      and
the        new         Li-Ion        battery.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK112998 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryAUTOPULSE RESUSCITATION SYSTEM MODEL 1000 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantZoll Circulation [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeDRM [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2012-03-15 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2011-10-07 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[127419] · record 048c553a3df446c4324f0773a8c5be1b291ddacdbc45f1f4941a7018dac53bba
  • [4] Complete results array / fda-decision-context:K112998 · record whole dataset partition

FDA 510(k) summary — K112998 ↗

Mon, 23 Apr 2012 04:33:39 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot acaef5e0384b5924e70d3e13df465826f060815bbf405ae5b2f01a29d9696d60

  • [2] PDF page 6 · record 35aa837d484cd5cd3a5d3075090c48a13fe5a8c8344335c8e892f8d558b7d08c
  • [3] PDF page 2 · record 6772a165e9b5f8b239d84fc07b26d9dbc6f6810694069853333d1a02143975a8

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services